Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,642 | -61,226 | -44,487 | -26,160 | -11,312 |
| Depreciation Amortization | 1,988 | 4,430 | 3,183 | 1,768 | 841 |
| Accounts payable and accrued liabilities | 2,823 | -473 | 1,794 | 674 | 2,612 |
| Other Working Capital | -4,436 | 45,196 | 48,613 | 42,225 | 43,989 |
| Other Operating Activity | -1,267 | 6,957 | 2,881 | 1,798 | -1,526 |
| Operating Cash Flow | $-25,534 | $-5,116 | $11,984 | $20,305 | $34,604 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,460 | -27,900 | -42,028 | -42,103 | -63,244 |
| PPE Investments | -135 | -4,660 | -4,341 | -2,038 | -1,007 |
| Investing Cash Flow | $-3,595 | $-32,560 | $-46,369 | $-44,141 | $-64,251 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 35,000 | 35,000 | 35,000 | 35,000 |
| Debt Repayment | -106 | -865 | -816 | -17 | N/A |
| Common Stock Issued | 30,640 | 106 | 88 | N/A | N/A |
| Other Financing Activity | 37,208 | -922 | 505 | 0 | 0 |
| Financing Cash Flow | $67,742 | $33,319 | $34,777 | $34,983 | $35,000 |
| Beginning Cash Position | 24,194 | 28,551 | 28,551 | 28,551 | 28,551 |
| End Cash Position | 62,807 | 24,194 | 28,943 | 39,698 | 33,904 |
| Net Cash Flow | $38,613 | $-4,357 | $392 | $11,147 | $5,353 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,534 | -5,116 | 11,984 | 20,305 | 34,604 |
| Capital Expenditure | -135 | -4,660 | -4,341 | -2,038 | -1,007 |
| Free Cash Flow | -25,669 | -9,776 | 7,643 | 18,267 | 33,597 |